Solubility, Polymorphism, Crystallinity, Crystal Habit, and Drying Scheme of (R, S)-(±)-Sodium Ibuprofen Dihydrate - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Solubility, Polymorphism, Crystallinity, Crystal Habit, and Drying Scheme of (R, S)-(±)-Sodium Ibuprofen Dihydrate
The racemic compound (R, S)-(±)-ibuprofen is a popular and well understood active pharmaceutical ingredient, but it has several disadvantageous formulation properties such as poor solubility, low melting point, and potential esterification with excipients containing an hydroxyl group. The authors investigate the use of an (R, S)-(±)-ibuprofen salt to evaluate these problems using various analytical methods to determine the polymorphism, crystallinity, and drying scheme.


Pharmaceutical Technology


Results and discussion


Figure 3
(R, S)-(±)-sodium ibuprofen dihydrate dissolved well in nine good solvents in Classes 4 and 5: tetrahydrofuran (THF), n-butyl alcohol, isopropyl alcohol (IPA), benzyl alcohol, N,N-dimethylformamide (DMF), ethanol, dimethyl sulfoxide (DSMO), methanol, and water. The compound only slightly dissolved in n-heptane, xylene, p-xylene, ethyl acetate, toluene, methyl-tert-butyl ether, benzene, methyl ethyl ketone, chloroform, N,N-dimethylaniline, acetone, 1,4-dioxane, nitrobenzene, and acetonitrile with a solubility of <1 mg/mL at 25 °C, giving 14 bad solvents in Classes 1, 2, and 3. Only nine solubility curves of (R, S)-(±)-sodium ibuprofen dihydrate in nine good solvents at 15, 25, 40, and 60 °C were constructed and grouped by their similar solubility ranges for ease of comparison (see Figure 3).

If the solute and the solvent formed an ideal solution, a straight line should result when ln x was plotted against 1/T according to the van't Hoff equation (13):











Figure 4
in which x is the mole fraction of (R,S)-(±)-sodium ibuprofen dihydrate in the solution at a given temperature (T) measured in K, converted from the solubility curves in Figure 3, and Rg was the ideal gas enthalpy constant (8.314 J/mol • K). Any deviation from the ideal solution behavior would be reflected from the correlation coefficient (R) of the linear fit in Figure 4. The relatively high correlation coefficients with values > 0.97 of the solvent systems, except for the one of DMSO, indicated that the solubility measurements by gravimetric titration were quite accurate, and the deviation of the solution from ideality was negligible. The enthalpy of dissolution (ΔHd)and the entropy of dissolution (ΔSd) were estimated from the slope and the y-intercept of the straight lines in Figure 4, respectively.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here